Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness
Year: 2022
Type: erratum
Abstract: In the version of this article initially published, the surname of author Chaitanya Bandlamudi was misspelt as Bandlamundi. The error has been corrected in the HTML and PDF versions of the article
Source: Nature
Authors: David Hoyos, Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin César de Andrade, Dean F. Bajorin, Chaitanya Bandlamudi, Margaret K. Callahan, Samuel A. Funt, Sine R. Hadrup, Jeppe S. Holm, Jonathan E. Rosenberg, Sohrab P. Shah, Ignacio Vázquez-García, Britta Weigelt, Michelle Wu, Dmitriy Zamarin, Laura F. Campitelli, Edward J. Osborne, Mark Klinger, Harlan S. Robins, Payal P. Khincha, Sharon A. Savage, Vinod P. Balachandran, Jedd D. Wolchok, Matthew D. Hellmann, Taha Merghoub, Arnold J. Levine, Marta Łuksza, Benjamin D. Greenbaum
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Swim Across America, Weill Cornell Medicine, National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Technical University of Denmark, Adaptive Biotechnologies (United States), Institute for Advanced Study, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $11,390
OpenAlex ID: W4281620419
